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The pathogenesis of hidradenitis sup-
purativa/acne inversa (HS) is still un-
clear, but is likely initiated by follicular
occlusion of the pilosebaceous-
apocrine units (Hoffman et al., 2017)
in the apocrine gland-rich (AGR) skin
(armpits, intramammary fold, genital
groin, perianal areas, and buttocks).
The outstanding role of keratinocytes in
the initiation phase was also high-
lighted by recently described signaling
pathways (Notch and mTOR signaling,
IL-36 pathway) related to HS patho-
physiology (Balato et al., 2019; Di
Caprio et al., 2017; Scala et al.,
2018). Following keratinocyte activa-
tion, proliferation and follicular
occlusion, immune cell infiltration,
pro-inflammatory cytokine, and
chemokine and antimicrobial peptide
(AMP) production resulting in
severe destruction of the surrounding
tissue lead to fully developed immune-
mediated inflammation.
In HS, IL-17 levels have been shown
to be elevated (Schlapbach et al., 2011;
Wolk et al., 2011) and IL-17 was
proven to be produced mainly by in-
flammatory T helper 17 type lympho-
cytes (Kelly et al., 2015; Schlapbach
et al., 2011). IL-17 is a multifaceted
cytokine that has both physiologicaland pathological, or in another classi-
fication non-inflammatory and inflam-
matory, roles at least on three different
levels: i) During homeostatic condi-
tions, it has a role in maintaining
immune surveillance of barriers that
cooperate with commensals; ii) it can
also protect barrier surfaces during the
invasion of extracellular pathogens;
whereas iii) it appears to be one of the
most prominent factors in the initiation
and maintenance of autoimmunity and
chronic inflammation (Abusleme and
Moutsopoulos, 2017).
In our previous studies (Beke et al.,
2018; Dajnoki et al., 2017), we re-
ported that sebaceous glanderich skin
areas, considered as oily skin, similarly
to the previously published topograph-
ical distinctions of the microbiota and
the chemical milieu (Bouslimani et al.,
2015; Grice and Segre, 2011), are
equipped with a significantly different
immune and barrier supply compared to
sebaceous gland-poor areas, considered
as dry skin. In the present project, we
aimed to further analyze whether AGR
areas (as analogous to moist skin in
previous literature) also develop their
characteristic immune and barrier
milieu because these skin regions were
proven to possess specific microbiota
composition, chemical milieu, moisturecontent, and temperature appreciably
different from apocrine gland-poor
(AGP) skin (AGP skin biopsies were
taken also from dry skin, similarly to
previous sebaceous gland-poor bi-
opsies, containing neither apocrine nor
sebaceous glands, detailed identifica-
tion in Supplementary Table S1 online)
(Grice and Segre, 2011). We were
interested in whether AGR skin’s im-
mune characteristics could predispose
this region to develop specifically an IL-
17-mediated inflammation, and also
aimed to search for the downstream tis-
sue effects of IL-17 in HS, because a
systematic survey was missing.
Biopsies from axillary region (repre-
senting moist AGR skin, n¼ 8) and from
shin and arm areas (representing dry
AGP skin, n ¼ 8) of healthy individuals
and lesional axillary skin of HS patients
(n ¼ 8) were gained (Supplementary
Table S1), after obtaining written
informed consent, according to the
Declaration of Helsinki principles, and
analyzed by quantitative real-time PCR
and immunohistochemistry (IHC),
which was quantified by Panoramic
Viewer software (3DHISTECH, Buda-
pest, Hungary) after whole slide imag-
ing. First, dendritic cell (DC) and T-cell
characteristics of AGR were compared
to AGP, then HS to AGR. The study was
approved by the local ethics committee
of University of Debrecen, Hungary.
IHC revealed significantly elevated
numbers of CD11cþ DCs and CD4þ T
cells in AGR region compared to AGP,
without prominent DC activation.
Although quantitative real-time PCR
analyses showed no significant differ-
ences between the two regions in the
Table 1. Comparison of immune and barrier components’ expression in apocrine gland-poor, apocrine gland-rich,
and hidradenitis suppurativa skin1
Variable
AGR vs AGP HS vs AGR
qRT-PCR IHC
References3
qRT-PCR IHC
References3P-Value
AGR vs AGP
(FC) P-Value
AGR vs AGP
(FC)2 P-Value
HS vs AGR
(FC)2 P-Value
HS vs AGR
(FC)2
Components of adaptive
immune response
Cellular components
CD4þ T cells nd nd <0.0001 4.02 [ # nd nd <0.0001 3.02 [ 1e3
CD11cþ DCs nd nd 0.001 2.99 [ # nd nd 0.038 1.74 [ 3,4
CD80þ cells 0.825 0.83 nd nd # 0.018 18.39 [ nd nd #
CD83þ cells 0.714 1.26 0.020 2.25 [ # 0.008 2.26 [ 0.003 2.90 [ #
CD86þ cells 0.683 0.70 nd nd # 0.004 2.94 [ nd nd #
CD1aþ DCs nd nd 0.286 1.06 # nd nd 0.302 1.10 #
CD163þ cells nd nd 0.111 2.12 # nd nd 0.004 6.02 [ 4
Th17-related factors
IL-17A 0.191 0.61 0.0003 UDL in AGP # <0.0001 167.45 [ 0.001 4.98 [ 1e3,5
IL-10 0.322 0.72 0.0003 2.31 [ # 0.111 2.26 <0.0001 4.8 [ 2,3,6,7
IL-1B 0.786 2.33 nd nd # 0.032 40.24[ nd nd 2,7
IL-6 0.333 1.01 nd nd # 0.206 1.66 nd nd 3,6
IL-23A 0.481 1.22 nd nd # 0.001 3.43 [ nd nd 1
TGFB1 0.206 0.71 nd nd # 0.016 2.61 [ nd nd 6
RORC 0.095 0.82 nd nd # 0.056 0.43 nd nd #
Th1-related factors
IL-12B 0.500 UDL in AGP nd nd # 0.036 8.26 [ nd nd 2,3
TBX21 0.536 0.74 nd nd # 0.016 6.18 [ nd nd #
IFNG 0.600 0.85 0.005 UDL in AGP # 0.267 7.63 0.005 11.01 [ 2,3,5,7
TNFA4 0.222 0.62 0.083 UDL in AGP # 0.016 1.90 [ 0.001 22.61 [ 4,7e9
Th2-related factors
IL-13 UDL UDL 0.142 2.12 # UDL UDL 0.143 1.47 3,10
GATA3 0.222 0.65 nd nd # 0.008 0.24 nd nd #
Th22-related factors
IL-22 UDL UDL nd nd # 0.050 UDL in AGR nd nd 2,5
AHR 0.155 1.59 0.494 0.74 # 0.004 3.97 [ 0.13 0.51 #
Treg-related factors
FOXP3 >0.999 1.12 nd nd # 0.229 1.57 nd nd 11
CCR4 >0.999 1.10 nd nd # 0.032 4.32 nd nd #
CCR8 0.714 0.70 nd nd # 0.802 0.90 nd nd #
Components of innate
immune response
and barrier molecules
Chemokines
CCL24 0.714 1.37 0.004 5.08 [ # 0.222 1.59 0.012 4.64 [ #
CCL204 0.857 0.73 0.004 2.4 [ # 0.016 3.89 [ 0.004 6.79 [ 5
CCL3 0.714 0.66 nd nd # 0.016 15.94 [ nd nd #
CCL19 0.857 0.82 nd nd # 0.029 4.05 [ nd nd #
CCL23 0.413 1.23 nd nd # 0.016 2.36 [ nd nd #
CCL24 0.250 2.69 nd nd # 0.571 1.59 nd nd #
Antimicrobial peptides
TSLP 0.397 0.84 0.006 331.56 [ # 0.437 0.91 0.179 1.24 #
S100A74 0.413 1.06 nd nd # 0.016 27.62 [ nd nd 2,9,12
S100A84 0.667 1.21 0.171 2.34 # 0.016 30.75 [ 0.029 5.82 [ 2,12,13
S100A94 0.413 1.70 nd nd # 0.016 28.38 [ nd nd 2,12,13
DEFB4B4 0.571 2.02 nd nd # 0.016 113.67 [ nd nd 6,8,12
LCN24 0.310 3.87 0.004 1.38 [ # 0.008 7.13 [ 0.018 6.4 [ 14
(continued )
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IHC both IL-17þ and IL-10þ cells were
detected in significantly elevatednumbers in AGR and were nearly ab-
sent from AGP. Moreover, a few IFN-gþ
cells were found in AGR only, and weretotally absent from AGP (Table 1,
Supplementary Figures S1 and S2
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Table 1. Continued
Variable
AGR vs AGP HS vs AGR
qRT-PCR IHC
References3
qRT-PCR IHC
References3P-Value
AGR vs AGP
(FC) P-Value
AGR vs AGP
(FC)2 P-Value
HS vs AGR
(FC)2 P-Value
HS vs AGR
(FC)2
Barrier molecules
LOR4 0.825 1.02 0.158 0.74 # 0.310 0.69 0.036 0.7 Y #
FLG4 0.110 1.68 0.037 0.8 Y # 0.395 2.99 0.095 1.60 #
CLDN1 0.679 1.31 nd nd # 0.310 0.67 nd nd #
KRT174 0.262 1.10 0.329 1.14 # 0.009 2.94 [ 0.008 5.62 [ 15,16
KRT79 0.036 14.55 [ nd nd # 0.222 0.44 nd nd #
Proinflammatory
molecules
TLR2 0.825 1.25 nd nd # 0.048 5.16 [ nd nd 4,6
TLR4 >0.999 0.88 nd nd # 0.018 3.38 [ nd nd 6
NLRP3 0.191 0.91 nd nd # 0.071 4.21 nd nd 13
IL-1B4 0.786 2.33 nd nd # 0.032 40.23 [ nd nd 2,7
TNFA4 0.222 0.62 0.083 UDL in AGP # 0.016 1.89 [ 0.001 22.61 [ 4,7e9
Abbreviations: AGP, apocrine glandepoor; AGR, apocrine glanderich; CCL, chemokine (C-C motif) ligand; DC, dendritic cell; FC, fold change; HS,
hidradenitis suppurativa; IHC, immunohistochemistry; nd, not determined; qRT-PCR, quantitative real-time PCR; Th, T helper; TGFB, transforming growth
factoreb; TLR, Toll-like receptor; TNFA, tumor necrosis factorea; Treg, regulatory T; UDL, under detection limit.
1Statistical analyses between protein and mRNA levels were determined by one-way analysis of variance followed by NewmaneKeuls post-hoc test. Bold
type indicates data with significant differences.
2Arrows indicate the direction of significant changes.
3# represents data that are previously unreported, to our knowledge. Eight samples were examined in each group regarding all the investigated molecules.
Numbers (1e16) represent publications of other groups in connection with the given molecules in HS. The list of these publications can be found in the
Supplementary References online.
4IL-17erelated (downstream) factor.
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966In HS, the numbers of DCs and T
cells further and significantly increased,
DCs became activated, and CD163þ
macrophages appeared in a signifi-
cantly enhanced number compared to
AGR (IHC). Significantly higher
expression of T-helper 17erelated (IL-
1B, IL-17A, IL-23A, transforming
growth factoreb1) and even T-helper
1erelated molecules (IL-12B, TBX21,
tumor necrosis factorea) were detected
at the mRNA level. Furthermore, by
IHC, the number of IL-17þ and IL-10þ
cells further and significantly increased,
and a robust presence of tumor
necrosis factoreaþ and IFN-gþ cells
became detectable (Table 1,
Supplementary Figures S1, S2, and S3
online).
In the second part of our experi-
ments, we investigated important che-
mokines, AMPs, barrier and pro-
inflammatory molecules of the skin
immune system. Although, when
comparing AGR to AGP skin, no sig-
nificant difference could be detected at
the mRNA level, except for the higher
expression of KRT79 in AGR, protein
levels of IL-17erelated chemokines
(CCL2, CCL20), AMPs (TSLP, LCN2),
and one of the barrier molecules (FLG)Journal of Investigative Dermatology (2019), Volumwere significantly altered in AGR
(Table 1, Supplementary Figure S3).
When comparing HS and AGR sam-
ples, quantitative real-time PCR
revealed significantly increased
expression of chemokines (CCL3,
CCL19, CCL20, CCL23) and AMPs
(DEFB4B, S100A7, S100A8, S100A9,
LCN2), as well as altered mRNA level
of KRT17 barrier molecule in HS. The
significantly and highly elevated level
of T-helper 17erelated chemokines
(CCL2, CCL20) and AMPs (S100A8,
LCN2) were also confirmed by IHC,
together with the altered expression of
barrier molecules (KRT17, LOR), which
also reflected an IL-17 effect (Table 1,
Supplementary Figure S3).
Expression of pro-inflammatory mol-
ecules (Toll-like receptor 2, Toll-like
receptor 4, NLRP3, IL-1b, tumor ne-
crosis factorea) was low in both AGP
and AGR, while in HS, a robust and
significant increase was observed in
their mRNA and protein levels, with the
exception of NLRP3 (Table 1,
Supplementary Figure S3).
In our present study, we could
unambiguously show that moist/AGR
skin possesses distinct immune and
barrier milieu compared to dry/AGPe 139areas. This is a non-inflammatory IL-17/
IL-10econtaining environment with
significantly higher T cell and DC
attendance, without any signs of acti-
vation or inflammation, accompanied
by IL-17erelated chemokines, AMPs,
and barrier characteristics. TSLP pres-
ence can be considered as part of the
homeostatic immune milieu of AGR,
similar to sebaceous glanderich skin or
the colonic mucosa (Dajnoki et al.,
2017; Ziegler and Artis, 2010).
Previous data have shown a subclin-
ical inflammatory state preceding the
manifestation of HS, which is started
with an aberrant keratinocyte response
to commensal follicular bacteria (Kelly
et al., 2014; Prens and Deckers,
2015). Healthy AGR skin disposes
region-specific microbiota influenced
by the chemical milieu, moisture con-
tent, and temperature of this area, but
in accordance with our present results,
this specific commensal population can
live in a homeostatic state with the
region-specific immune and barrier
milieu of AGR skin. We hypothesize
that, during the development of HS, this
“AGR-specific” homeostatic symbiosis
between microbiota and skin immune
system can be modified (or not fully
Figure 1. Apocrine glanderich skin has a non-inflammatory IL-17erelated immune milieu, which turns to inflammatory IL-17emediated disease in
hidradenitis suppurativa. Healthy apocrine glanderich skin disposes region-specific microbiota, but this specific commensal population can live in a
homeostatic state with the region-specific immune and barrier milieu of apocrine gland-rich skin. During development of hidradenitis suppurativa, this
“apocrine glanderich-specific” homeostatic symbiosis between microbiota and skin immune system can be modified (or not even fully developed), and this
breakdown of the non-inflammatory IL-17/IL-10 milieu leads to a severe IL-17/IFN-getype inflammation in hidradenitis suppurativa. Microbiota of healthy
apocrine glanderich and lesional hidradenitis suppurativa skin was presented according to the findings of Grice and Segre (2011) and Ring et al. (2017),
respectively. AGR, apocrine gland-rich; CCL, Chemokine (C-C motif) ligand; DC, dendritic cell; HS, hidradenitis suppurativa; Th17(b), non-inflammatory
T-helper 17; Th17(23), inflammatory T-helper 17; TLR, Toll-like receptor; TNF-a, tumor necrosis factorea.
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non-inflammatory IL-17/IL-10 milieu
leads through a gradual subclinical
progression to a severe IL-17/IFN-
getype apparent inflammation in HS
(Figure 1). The mentioned patho-
mechanism of HS highly resembles that
of Crohn’s disease, as proposed by
current literature (Maloy and Powrie,
2011; van der Zee et al., 2016), which
can be an additional link between the
two diseases.
The data of our study also suggest
that the non-inflammatory IL-17 milieu
of AGR skin may prone this area to
develop specifically an IL-17 type in-
flammatory disease, as all the charac-
teristic adaptive and innate immune or
barrier features of AGR skin were also
present in HS in robust and widespread
forms, accompanied by activation and
inflammation markers, ultimatelyresulting in a full-blown inflammatory
IL-17 environment (Table 1,
Supplementary Figures S1eS3). This
inflammatory IL-17 milieu was re-
flected by significant chemokine, AMP,
and barrier alterations (Table 1). High
IFN-g and tumor necrosis factorea
presence in HS was also confirmed by
this study, although previous literature
data were inconsistent regarding their
levels (Kelly et al., 2014).
In conclusion, our previous and
present data suggest that not only the
microbiota and chemical content of
human skin show three main topo-
graphical areas (dry, moist, oily/
sebaceous), but probably in correla-
tion to this, the immune and barrier
characteristics of these topographical
regions are also distinct, which can
make these skin regions become
prone to the development of “region-specific” inflammatory skin diseases,
like HS on AGR and acne (Mattii
et al., 2018) and rosacea (Dajnoki
et al., 2017) on sebaceous gland-
rich areas.
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Atopic dermatitis (AD) is a common
chronic recurrent allergic skin disease
with an estimated prevalence of 10% in
adult humans and up to 20% in chil-
dren; the salient immune-mediated
clinical features of this disease havebeen reviewed recently (Weidinger and
Novak, 2016). In the last decade, much
progress has been made to better char-
acterize the pathogenesis of human
AD. The pathomechanism of human
AD involves the complex interplay of
primary and secondary epidermalbarrier defects with associated T-helper
(Th) 2 and Th22 immune responses in
most individuals, with a more complex
reaction in children and some Asian
subpopulations, who also exhibit a
Th17 polarization (Brunner et al., 2017;
Weidinger and Novak, 2016).
Animal models play a critical role for
studying the mechanism of lesion for-
mation and developing novel therapies
for AD. Although various domestic an-
imals are affected by eczema (Einhorn
et al., 2018; Gershwin, 2015), dogs
